Related by context. All words. (Click for frequent words.) 71 achieved CCyR 71 recurrent glioblastoma multiforme 70 adalimumab Humira 70 mitoxantrone plus 70 refractory NSCLC 70 relapsed MM 70 abacavir lamivudine 69 interferon ribavirin 69 FUSILEV enhances 69 mRCC 69 coinfected patients 68 moderate renal impairment 68 estramustine 68 detectable HCV RNA 68 FOLFIRI alone 68 CYP#A# substrate 68 perioperatively 68 HBeAg negative patients 68 APTIVUS r 68 cisplatin chemotherapy 68 deep venous thromboses 68 pamidronate 68 Adjuvant chemotherapy 68 infliximab monotherapy 68 octreotide LAR 68 INVEGA ® 67 anthracycline taxane 67 Flu Cy 67 achieved ACR# 67 mutated KRAS 67 stage IIIb IV 67 candidemia 67 hepatorenal syndrome 67 FOLFOX4 67 8mg/kg 67 mCRC patients 67 HBeAg + 67 IFN alfa 67 KRAS mutations occur 67 resected pancreatic cancer 67 chlorambucil 67 antiretroviral naive 67 gemifloxacin 67 plus OBT 67 myelodysplastic myeloproliferative diseases 67 metastatic renal cell carcinoma 67 bone marrow reticulin deposition 67 pegylated liposomal doxorubicin 67 HBeAg seroconversion 67 paricalcitol 66 BARACLUDE ® 66 TTF Therapy 66 ribavirin therapy 66 docetaxel chemotherapy 66 adriamycin 66 metastatic RCC 66 heavily pretreated 66 ACTEMRA TM 66 doxorubicin cyclophosphamide 66 AGILECT R 66 colorectal liver metastases 66 Doxil ® 66 Refractory Hodgkin Lymphoma 66 squamous histology 66 preoperative chemotherapy 66 alfa 2a 66 selective modulator 66 receiving XGEVA 66 mitoxantrone 66 Gleevec resistant 66 trastuzumab Herceptin ® 66 receiving VELCADE 66 nicardipine 66 mycophenolic acid 66 mycophenolate mofetil 66 genotypic resistance 66 5-FU/LV 66 receiving golimumab 66 CCyR 66 4mg/kg 66 PREZISTA r 66 Newly Diagnosed Multiple Myeloma 66 receiving prophylactic anticoagulation 66 evaluating tivozanib 66 CR nPR 66 unresectable HCC 66 CIMZIA TM certolizumab pegol 66 ZOLINZA 65 metastatic GIST 65 cabazitaxel 65 flutamide 65 relapsed CLL 65 oral clodronate 65 erlotinib Tarceva ® 65 K ras mutations 65 EGFR mutation positive 65 alkylating agent 65 biochemical relapse 65 Folfox 65 dexamethasone Decadron 65 amoxicillin clavulanate 65 invasive fungal infection 65 rimonabant #mg 65 Mg Usa 65 diabetic gastroparesis 65 HBeAg 65 invasive aspergillosis 65 basiliximab 65 posaconazole 65 pentoxifylline 65 HIV HCV coinfected 65 Castration Resistant Prostate Cancer 65 renal toxicity 65 dalteparin 65 vinorelbine 65 MAGE A3 ASCI 65 placebo dexamethasone 65 CIMZIA ™ 65 gemcitabine cisplatin 65 palifermin 65 desvenlafaxine succinate 65 piperacillin tazobactam 65 plus prednisone prednisolone 65 divalproex sodium 65 β blockers 65 plus dexamethasone 65 panitumumab Vectibix 65 voriconazole 65 Known hypersensitivity 65 amphotericin B 65 ritonavir boosted 65 CANCIDAS 65 blastic phase 65 EXJADE 65 naïve HCV 65 hepatic metastases 65 fluorouracil 65 RLAI 65 interferon alfa 2b 65 baseline LDH 65 receiving immunosuppressive therapy 65 chemoradiation therapy 65 nephrotoxicity 65 tolterodine ER 65 maximal doses 65 bleomycin 65 rituximab Rituxan 65 receptor tyrosine kinase inhibitor 65 5FU 65 CsA 65 mg TID 65 severe renal impairment 65 oral vancomycin 65 daunorubicin 65 known sulfonamide allergy 65 gastrointestinal stromal tumor GIST 65 PREZISTA rtv 65 relapsed ovarian cancer 64 reduce serum phosphate 64 Platinol ® cisplatin 64 FluCAM 64 advanced adenomas 64 hour bronchodilation 64 vandetanib 64 6 mercaptopurine 64 FOLFOX6 64 antiandrogen 64 Fludara 64 anthracyclines taxanes 64 Peginterferon alfa 2b 64 mg kg dose 64 mcg QD 64 leucopenia 64 PegIFN RBV 64 diabetic kidney 64 Myelodysplastic Syndrome MDS 64 ARCALYST ® 64 metastatic colorectal carcinoma 64 chronic HBV 64 adefovir 64 denileukin diftitox 64 % CI #.#-#.# [007] 64 calcineurin inhibitor 64 azacitidine 64 decitabine 64 baminercept 64 Platinol ® 64 metastatic malignant 64 bezafibrate 64 unresectable stage 64 neurologic progression 64 metastatic kidney 64 metastatic gastric 64 TAXOTERE R 64 mcg kg REBETOL 64 biliary tract cancer 64 pCR 64 recurrent metastatic 64 recurrent genital herpes 64 venlafaxine XR 64 HBeAg negative 64 caspofungin 64 CAELYX 64 Alkeran 64 3TC lamivudine Epivir 64 Aptivus ® 64 sunitinib Sutent ® 64 % CI #.#-#.# [003] 64 gemcitabine carboplatin 64 prednisone prednisolone 64 receiving INTRON 64 SCIg 64 dasatinib Sprycel ® 64 achieve sustained virologic 64 ribavirin RBV 64 Postoperatively 64 peginterferon alfa 64 plus methotrexate 64 intravenous bisphosphonates 64 ertapenem 64 VaD 64 forodesine 64 AVASTIN 64 corticosteroid therapy 64 doxorubicin Adriamycin 64 relapsed ALL 64 galiximab 64 lenalidomide Revlimid R 64 severe neutropenia 64 cilengitide 64 Xelox 64 mild renal insufficiency 64 autoantibody positive 64 weekly subcutaneous injections 64 Pemetrexed 64 clodronate 64 sotalol 64 mutated KRAS gene 64 recurrent malignant glioma 64 severe exacerbations 64 microbiological eradication 64 Xeloda ® 64 Febrile neutropenia 64 paclitaxel cisplatin 64 leukemia AML 64 Velcade bortezomib 64 gastrointestinal stromal tumors GIST 64 interferon alfa 2a 64 AZT zidovudine Retrovir 64 Mg Uk 64 atazanavir ritonavir 64 rizatriptan 64 ® lenalidomide 64 Femara letrozole 64 imatinib Gleevec 64 EGFR TKI 64 adjunctive placebo 64 VELCADE melphalan 64 HBeAg positive 64 Thalomid ® 64 progesterone receptor negative 64 plus aztreonam 64 efalizumab 64 oral rivaroxaban 64 relapsing remitting MS RRMS 64 Bezielle 64 imatinib therapy 64 Pharmacokinetics PK 64 TNF antagonist 64 FOLFOX4 alone 64 factor TNF 64 HIV coinfected 64 salmeterol fluticasone 64 systemic immunosuppressive 64 nutlin 3a 64 SPRYCEL ® 63 idarubicin 63 achieved PASI 63 Toxicities 63 CIMZIA TM 63 Paraplatin ® 63 comparator arm 63 epoetin beta 63 sorafenib tablets 63 complete cytogenetic response 63 olmesartan 63 micafungin 63 cisplatin gemcitabine 63 amisulpride 63 plus gemcitabine 63 IFN beta 63 clomipramine 63 invasive candidiasis 63 T#I [002] 63 fluticasone salmeterol 63 Pegylated Interferon 63 gefitinib Iressa 63 TAXOTERE ® 63 #mg/day [001] 63 HER2 overexpression 63 NMIBC 63 STELARA ® 63 isoproterenol 63 cinacalcet 63 H. pylori eradication 63 gemcitabine chemotherapy 63 ALT normalization 63 bosentan 63 lymphocytosis 63 fibrinolytic therapy 63 elevated transaminases 63 Vidaza azacitidine 63 neutropenic sepsis 63 ORENCIA ® 63 pegaptanib 63 cetuximab Erbitux R 63 moderate hepatic impairment 63 mapatumumab 63 5 FU leucovorin 63 steroid dexamethasone 63 itraconazole 63 hemorrhagic cystitis 63 lumbar spine BMD 63 free survival PFS 63 docetaxel Taxotere ® 63 anakinra 63 TMP SMX 63 transaminase elevations 63 doxazosin 63 canakinumab 63 indinavir 63 insulin detemir 63 imipenem 63 antiretroviral naïve 63 FOLFIRI 63 acute gout flares 63 HBeAg positive patients 63 VIRAMUNE XR 63 Thal Dex 63 locoregional 63 postoperative AF 63 tirofiban 63 lenalidomide dexamethasone 63 mcg BID 63 cyclophosphamide Cytoxan 63 tumors GIST 63 Navelbine 63 hepatitis C genotype 63 PASI scores 63 interferon alfa 63 receiving VICTRELIS 63 5 Fluorouracil 63 heavily pretreated patients 63 interferon gamma 1b 63 tolterodine 63 pharmacokinetic interactions 63 methotrexate monotherapy 63 Mitoxantrone 63 carboplatin paclitaxel 63 experienced virologic failure 63 PSADT 63 Hormone Refractory Prostate Cancer 63 Nebulized 63 darunavir r 63 interferon therapy 63 administered concomitantly 63 pegylated interferon alpha 63 treatment naive genotype 63 INSPIRE Trial Phase III 63 pegylated interferon peg IFN 63 Noxafil 63 advanced adenoma 63 conventional DMARDs 63 achieved sustained virological 63 NATRECOR R 63 Interferon beta 1b 63 cyclophosphamide chemotherapy 63 demonstrated antitumor activity 63 ddI 63 PegIntron 63 PEGylated Fab fragment 63 FASLODEX 63 ritonavir boosted protease inhibitor 63 sitaxsentan 63 genotype 1b 63 progression TTP 63 icatibant 63 uric acid lowering 63 Capecitabine 63 Ribavirin causes 63 anterior uveitis 63 oxycodone CR 63 refractory gout 63 Chronic Hepatitis C 63 steroid refractory ulcerative 63 certolizumab 63 metastatic malignant melanoma 63 oblimersen 63 abacavir Ziagen 63 aprepitant 63 tipranavir r 63 refractory metastatic colorectal cancer 63 Jevtana 63 GnRH agonists 63 non mutated KRAS 63 ULORIC 63 Fludarabine 63 highly emetogenic 63 CHOP chemotherapy 63 smoldering multiple myeloma 63 Abrupt discontinuation 63 eribulin mesylate 63 cytarabine daunorubicin 63 aminotransferases 63 BEACOPP 63 hypophosphatemia 63 esophageal candidiasis 63 Kinoid 63 postoperative chemotherapy 63 Erythropoietic therapies may 63 MGd 63 virologic failure 63 Malignant Glioma 63 INTEGRILIN R 63 erlotinib Tarceva 62 refractory CML 62 Arranon 62 prospectively stratified 62 leukemia ALL 62 refractory chronic myeloid 62 lung metastases 62 pyridostigmine 62 curative resection 62 tipranavir ritonavir 62 imatinib Gleevec ® 62 basal cell carcinoma BCC 62 hepatic enzymes 62 cytoreduction 62 peginterferon alfa 2a 62 cardiotoxic 62 EGFR tyrosine kinase inhibitors 62 doxorubicin docetaxel 62 neoadjuvant therapy 62 ethambutol 62 Infusion Reactions Severe 62 #mg BID [001] 62 ALT flares 62 de novo AML 62 acarbose 62 colorectal adenoma 62 Severe Sepsis 62 HoFH 62 serum phosphorous 62 EDARBI 62 undetectable viral 62 Ceplene/IL-2 62 leukemia APL 62 alemtuzumab treated 62 glomerular filtration 62 de novo kidney transplant 62 CLL SLL 62 sulfasalazine 62 hypereosinophilic syndrome 62 HERCEPTIN 62 Decitabine 62 refractory ovarian cancer 62 CYT# potent vascular disrupting 62 DETROL LA 62 TroVax ® 62 patients receiving myelosuppressive 62 FLT3 ITD 62 eosinophilic asthma 62 #mg BID [003] 62 oxcarbazepine 62 nephropathic cystinosis cystinosis 62 prostate cancer CaP 62 pouchitis 62 NPH insulin 62 plus prednisone 62 psoriatic arthritis PsA 62 serum urate levels 62 #mg/day [002] 62 antirheumatic 62 Paraplatin ® carboplatin 62 docetaxel Taxotere 62 VFEND 62 KRAS wild 62 tigecycline 62 bendamustine 62 relapsed refractory AML 62 progressive PsA 62 decompensated liver disease 62 ß blockers 62 MULTAQ 62 antihypertensive therapy 62 Celsentri Selzentry 62 anagrelide 62 hepatic fibrosis 62 β blocker 62 pimozide 62 relapsed myeloma 62 oropharyngeal candidiasis OPC 62 hematologic toxicity 62 CK # administered 62 avosentan 62 splenectomized patients 62 macrolide antibiotic 62 Camptosar ® 62 refractory CLL 62 endometrial hyperplasia 62 minimally symptomatic 62 antibody MAb 62 advanced hepatocellular carcinoma 62 APTIVUS 62 recurrent NSCLC 62 postoperative morbidity 62 omega interferon 62 trimethoprim sulfamethoxazole 62 receptor inhibitor 62 phase IIb study 62 hepatocellular cancer 62 MYLOTARG 62 anthracycline containing 62 BEXXAR Therapeutic Regimen 62 papillary renal cell carcinoma 62 containing abacavir 62 aldosterone antagonists 62 operable breast cancer 62 Roche Herceptin 62 relapsed refractory multiple myeloma 62 rHuEPO 62 minimally symptomatic metastatic castrate 62 bevacizumab Avastin R 62 Taxotere chemotherapy 62 aripiprazole Abilify 62 allogeneic HSCT 62 thalidomide Thalomid 62 Peripheral edema 62 metastatic bladder 62 Irinotecan 62 Neovascular Age Related Macular 62 neoadjuvant chemotherapy 62 Cimzia TM 62 pegIFN 62 sunitinib 62 quetiapine Seroquel 62 budesonide pMDI 62 locoregional recurrence 62 neutrophil counts 62 tamoxifen Nolvadex ® 62 nonmetastatic 62 prostate cancer CRPC 62 skeletal metastases 62 Idiopathic Pulmonary Fibrosis 62 chronic eosinophilic leukemia 62 aromatase inhibitor therapy 62 liver histology 62 carcinoma mCRC 62 CrCl 62 del 5q MDS 62 hepatic function 62 pomalidomide 62 chronic HCV genotype 62 hematologic parameters 62 relapsing multiple sclerosis 62 Adalimumab 62 antithymocyte globulin 62 EGFRIs 62 Cloretazine 62 assessing T DM1 62 alpha interferons 62 nondiabetic patients 62 titrated glipizide 62 nitazoxanide 62 Vidaza ® 62 cervical lymph nodes 62 receiving ISENTRESS 62 somatostatin analogues 62 elevated ALT 62 intravascular hemolysis 62 metastatic lung cancer 62 androgen suppression 62 EGFR expressing mCRC 62 q8h 62 Mitomycin C 62 thrombocytopenic 62 nucleoside analogs 62 completely resected 62 Pioglitazone 62 prednisone prednisolone plus 62 EDSS scores 62 CTAP# 62 Peg IFN 62 virologically 62 ATACAND 62 systemic corticosteroid 62 sorafenib Nexavar 62 KRAS status 62 cyclophosphamide methotrexate 62 serum urate 62 mycophenolate mofetil MMF 62 invasive carcinomas 62 dopamine partial agonist 62 Hypotension 62 paclitaxel Taxol ® 62 mild hepatic impairment 62 Isentress raltegravir 62 Teriflunomide 62 zoledronate 62 nonalcoholic steatohepatitis NASH 62 adalimumab 62 anemia hemoglobin 62 chronic idiopathic thrombocytopenic purpura 62 parkinsonian symptoms 62 lopinavir r arm 62 recurrent GBM 62 virological failure 62 remission induction 62 beclomethasone dipropionate 62 morphometric vertebral fractures 62 fluvastatin 62 bortezomib refractory 62 pegylated interferon alfa 2a 62 mCRPC 62 patients coinfected 62 recurrent VTE 62 Natalizumab 62 Telintra 62 leukemia CLL 62 TNF blocker therapy 62 refractory chronic lymphocytic 62 serum aminotransferase levels 62 vismodegib 62 GW# [003] 62 Taxol paclitaxel 62 Median PFS 61 sargramostim 61 azathioprine 61 Mylotarg 61 paclitaxel Taxol R 61 undergone splenectomy 61 Cariprazine 61 zotarolimus 61 AML MDS 61 receiving highly emetogenic 61 secondary hyperparathyroidism 61 golimumab CNTO 61 serum calcium levels 61 non metastatic osteosarcoma 61 solifenacin 61 taxane chemotherapy 61 infliximab Remicade 61 ALT elevation 61 Advanced Melanoma 61 TO AVOID PREGNANCY WHILE 61 refractory colorectal cancer 61 Torisel 61 symptomatic hypotension 61 fluoropyrimidine 61 pT3 61 response CCyR 61 romiplostim 61 metastatic renal cell 61 induce remission 61 pulmonary exacerbations 61 INFERGEN 61 IRESSA 61 NNRTI resistance 61 mitoxantrone chemotherapy 61 cediranib 61 epithelial tumors 61 low dose cytarabine 61 HGS ETR1 mapatumumab 61 REYATAZ r arm 61 FluCAM arm 61 biologic DMARD 61 anthracycline chemotherapy 61 elevated serum creatinine 61 KETEK 61 Perforomist Inhalation Solution 61 virological response 61 Free Survival PFS 61 ciclosporin 61 methotrexate therapy 61 localized renal 61 ziprasidone 61 ovarian carcinoma 61 resistant hormone refractory 61 severe hypersensitivity reactions 61 oral chemotherapeutic agent 61 antiangiogenic therapy 61 Intravenous immunoglobulin 61 Riluzole 61 achieved sustained virologic 61 asymptomatic metastatic 61 stage IIIB 61 balsalazide 61 Peginterferon 61 BARACLUDE R 61 teriflunomide 61 placebo PBO 61 sulphonylureas 61 Diffuse Large B 61 essential thrombocythemia ET 61 primary hypercholesterolemia 61 LymphoStat B belimumab 61 atorvastatin #mg 61 reinfarction 61 mg ustekinumab 61 anastrazole 61 oral Hycamtin 61 beta 1a 61 recombinant erythropoietin 61 headache abdominal pain 61 underwent surgical resection 61 emtricitabine tenofovir 61 relapsed SCLC 61 Complicated Skin 61 EGFR mutations 61 CYP#D# genotype 61 perioperative complications 61 cis retinoic acid 61 nilotinib Tasigna ® 61 immunomodulatory therapy 61 mg RDEA# 61 R Saizen R 61 #mg/m# [002] 61 GG genotype 61 superficial bladder cancer 61 Gemzar gemcitabine 61 SMZ TMP 61 Relapsing Remitting Multiple Sclerosis 61 SGPT 61 XELOX 61 incidence ≥ 61 Bevacizumab Avastin 61 peginterferon 61 paclitaxel Taxol 61 Zavesca R 61 Peginterferon Alfa 2a 61 sorafenib 61 non splenectomized 61 drug eluting stent implantation 61 recurrent venous thromboembolism 61 Hepatocellular Carcinoma HCC 61 adverse cytogenetics 61 Dementia Related Psychosis 61 lupus nephritis 61 inhaled iloprost 61 headache nasopharyngitis 61 #mg dose [002] 61 unresectable tumors 61 venous thromboembolic events 61 #.#mg/dL 61 partial remissions 61 zolmitriptan 61 TNF Tumor Necrosis Factor 61 elevated triglyceride levels 61 ORENCIA R 61 low dose Iluvien 61 DOXIL 61 castrate resistant 61 mepolizumab 61 HER2 negative 61 lumiliximab 61 oral methylnaltrexone 61 thromboembolic complications 61 Bosutinib 61 Adefovir 61 ximelagatran 61 dopaminergic therapy 61 neostigmine 61 chemotherapy FOLFOX 61 quetiapine risperidone 61 induce orthostatic hypotension 61 Acute Exacerbations 61 Akt activation 61 T2DM 61 sorafenib Nexavar ® 61 venlafaxine Effexor 61 indolent follicular non 61 Copegus ribavirin 61 saline placebo 61 tapentadol ER 61 synovial fibroblasts 61 mL/min/#.# m 2 61 tenofovir emtricitabine 61 lichen planus 61 FOSRENOL ® 61 riociguat 61 dacarbazine DTIC 61 Progressive Multifocal Leukoencephalopathy 61 external genital lesions 61 glycoprotein IIb IIIa inhibitor 61 Certolizumab pegol 61 pegylated interferon alfa 61 FOLFOX 61 ziconotide 61 vincristine doxorubicin 61 idraparinux 61 relapsed multiple myeloma 61 dosing frequency 61 hormone receptor negative 61 warfarin erythromycin 61 ritonavir boosted atazanavir 61 peritoneal carcinomatosis 61 alefacept 61 mesalamine granules 61 atherosclerotic renal artery stenosis 61 irinotecan containing 61 oxaliplatin Eloxatin 61 rilonacept 61 daily subcutaneous injections 61 coadministration 61 active ankylosing spondylitis 61 prostate cancer mCRPC 61 malignant pleural effusion 61 PsA 61 weekly intravenous infusions 61 candesartan cilexetil 61 oral FTY# 61 HCV RESPOND 2 61 paclitaxel eluting stents 61 standard chemotherapy regimens 61 follicular lymphoma FL 61 levetiracetam 61 5-fluorouracil/leucovorin 61 subcutaneous enoxaparin 61 Anthracycline 61 Fludara ® 61 standard chemotherapy regimen 61 aldosterone antagonist 61 Elotuzumab 61 Losartan 61 Dasatinib 61 Nilotinib 61 R# #mg BID 61 adjuvant radiation 61 haloperidol Haldol 61 metastatic colorectal 61 potentially hepatotoxic 61 telaprevir dosed 61 hypomethylating agents 61 mu opioid receptor antagonist 61 cardiac toxicity 61 CC genotype 61 renal flares 61 interferon beta 1a infertility 61 antiandrogens 61 PROSTVAC VF 61 danazol 61 Metastatic Colorectal Cancer 61 mcg dose 61 Fluconazole 61 endocrine therapies 61 fosamprenavir 61 systemic ALCL 61 metastatic HRPC 61 amifostine 61 acetonide FA 61 MS relapses 61 fibrate drugs 61 cranial irradiation 61 myocardial reperfusion 61 postoperative delirium 61 Naive Patients 61 infusional 5-FU/LV 61 Pegylated Liposomal Doxorubicin 61 Cytoxan 61 beta blocker therapy 61 R abatacept 61 administered subcutaneously 61 vidofludimus 61 sunitinib Sutent 61 R lenalidomide 61 PEGINTRON TM 61 RAS mutations 61 variceal hemorrhage 61 nadolol 61 myopathy rhabdomyolysis 61 chemoradiotherapy 61 terazosin 61 Erlotinib 61 HER2 positive metastatic breast 61 recurrent glioblastoma 61 ara C 61 chemo radiotherapy 61 dose cohort 61 Serious adverse reactions 61 oxymorphone ER 61 corticosteroid dexamethasone 61 anti leukemic 61 paliperidone ER 61 Gleevec imatinib 61 locoregional disease 61 HBV infections 61 ARIMIDEX 61 oral antidiabetic medication 61 lopinavir r 61 nucleoside naive 61 tamsulosin 61 LHRH agonists 61 Cutaneous T 61 axitinib 61 insulin glulisine 61 BENICAR HCT 61 lung metastasis 61 hyperphenylalaninemia HPA due 61 #mg ATC 61 Epivir 61 liver metastasis 61 bronchodilatory 61 LEP ETU 61 mg/m2 administered 61 Atypical Hemolytic Uremic Syndrome 61 COMBIVIR 61 pooled comparator 61 adult chronic ITP 61 hypomagnesemia 61 virologic response 61 salmeterol HFA MDI 61 poor metabolizers 61 Triapine R 61 leukotriene receptor antagonist 61 motesanib 61 #mg dose [003] 61 systemic hypotension 61 androgen ablation 61 Cell Lymphoma CTCL 61 rituximab refractory 61 hypotensive 60 metastatic castration resistant 60 ritonavir boosted lopinavir 60 relapsed AML 60 protease inhibitor PI 60 SNT-MC#/idebenone 60 sitagliptin metformin 60 adjunctive ABILIFY 60 underwent resection 60 null responder 60 Subgroup analysis 60 thromboembolic events 60 Navelbine ® 60 epirubicin 60 atherothrombotic events 60 HMG CoA reductase inhibitors 60 TRAIL induced apoptosis 60 Tarceva TM 60 lapatinib Tykerb 60 MabThera Rituxan 60 HER2 expression 60 mg QD 60 AA Amyloidosis 60 R sorafenib tablets 60 pyrexia mucositis sepsis febrile 60 gemcitabine Gemzar 60 haematologic 60 oral levofloxacin 60 Fingolimod 60 risperidone Risperdal 60 MELD scores 60 oral ridaforolimus 60 TORISEL 60 patients evaluable 60 alanine aminotransferase 60 trastuzumab 60 severe oral mucositis 60 paclitaxel chemotherapy 60 humanised monoclonal antibody 60 delayed CINV 60 pancreatic neuroendocrine tumors 60 underwent liver transplantation 60 euthyroid 60 TEAEs 60 abiraterone acetate 60 dual endothelin receptor antagonist 60 peginterferon alpha 2a 60 trabectedin 60 TDF FTC 60 TYGACIL 60 imatinib resistant 60 molindone 60 KRAS mutations 60 MACUGEN 60 EFFEXOR XR 60 ZYVOX 60 lumbar disk herniation 60 bisoprolol 60 REVLIMID ® 60 proliferative diabetic retinopathy 60 VIIBRYD 60 VcMP 60 TEMODAL 60 alanine aminotransferase ALT 60 folinic acid 60 maximally tolerated lipid lowering 60 #mg QD [002] 60 lamivudine monotherapy 60 #I TM#